Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors

Journal of Neuro-Oncology

Volumn 66, Issue 1-2, 2004, Pages 179-185

  Fiorillo, Amedeo ^a   Maggi, Giuseppe ^b   Greco, Nicola ^a   Migliorati, Roberta ^a   D'Amico, Alessandra ^a   Del Basso De Caro, Marialaura ^a   Sabbatino, M Simona ^a   Buffardi, Floriana ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

Author keywords

Brain tumor; Carboplatin; Children; Liposomal daunorubicin; Malignant glioma; Prognosis

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HYDROXYUREA; PROCARBAZINE; SEROTONIN 3 ANTAGONIST; VINCRISTINE;

ARTICLE; BLOOD TOXICITY; BRAIN CANCER; BRAIN SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG RESPONSE; FEASIBILITY STUDY; FEMALE; HEARING IMPAIRMENT; HUMAN; MALE; NAUSEA AND VOMITING; RECURRENT CANCER; RHABDOID TUMOR; TERATOMA;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MALE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1342308343     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000013471.53015.52     Document Type: Article

References (22)

1. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK: Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17: 2572-2578, 1999
2. Huncharek M, Wheeler L, McGarry R, Geschwind JF: Chemotherapy response rates in recurrent/progressive pediatric glioma: Results of a systematic review. Anticancer Res 19: 3569-3574, 1999
3. Mason WP, Goldman S, Yates AJ, Boyett J, Li H, Finlay JL: Survival following intensive chemotherapy with bone marrow reconsitution for children with recurrent intracranial ependymoma - A report of the Children's Cancer Group. J Neuro-Oncol 37: 135-143, 1998
4. Bouffet E, Mottolese C, Jouvet A, Philip I, Frappaz D, Carrie C, Brunat-Mentigny M: Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas. Eur J Cancer 33: 91-95, 1997
5. McCowage GB, Friedman HS, Moghrabi A, Kerby T, Ferrell L, Stewart E, Duncan-Brown M, Fuchs HE, Tien R, McLendon RE, Meier L, Kurtzberg J, Ashley D, Colvin OM, Longee DC: Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas. Med Pediatr Oncol 30: 75-80, 1998
6. Hurwitz CA, Strauss LC, Kepner J, Kretschmar C, Harris MB, Friedman H, Kun L, Kadota R: Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: A pediatric oncology phase II study. J Pediatr Hematol Oncol 23: 277-281, 2001
7. Kadota RP, Stewart CF, Horn M, Kuttesch JF Jr, Burger PC, Kepner JL, Kun LE, Friedman HS, Heideman RL: Topotecan for the treatment of recurrent or progressive central nervous system tumors - A pediatric oncology group phase II study. J Neuro-Oncol 43: 43-47, 1999
8. Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DH Jr: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomised phase II study. J Clin Oncol 10: 249-256, 1992
9. Chamberlain MC: Recurrent intracranial ependymoma in children: Salvage therapy with oral etoposide. Pediatr Neurol 24: 117-121, 2001
10. Needle MN, Molloy PT, Geyer JR, Herman-Liu A, Belasco JB, Goldwein JW, Sutton L, Phillips PC: Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Pediatr Oncol 29: 28-32, 1997
11. Mulne AF, Ducore JM, Elterman RD, Friedman HS, Krischer JP, Kun LE, Shuster JJ, Kadota RP: Oral methotrexate for recurrent brain tumors in children: A Pediatric Oncology Group study. J Pediatr Hematol Oncol 22: 41-44, 2000
12. Warnick RE, Prados MD, Mack EE, Chandler KL, Doz F, Rabbit JE, Malec MK: A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neuro-Oncol 19: 69-74, 1994
13. Jeremic B, Grujicic D, Jevremovic S, Stanisavljevic B, Milojevic L, Djuric L, Mijatovic L: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: A phase II study. J Clin Oncol 10: 1074-1077, 1992
14. Koukourakis MI, Koukouraki S, Fezoulidis I, Kelekis N, Kyrias G, Archimandritis S, Karkavitsas N: High intra-tumoral accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumors. Br J Cancer 83: 1281-1286, 2000
15. Zucchetti M, Boiardi A, Silvani A, Parisi I, Piccolrovazzi S, D'Incalci M: Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin. Cancer Chemother Pharmacol 44: 173-176, 1999
16. Albrecht KW, De Witt Hamer PC, Leenstra S, Bakker PJ, Beijnen JH, Troost D, Kaaijk P, Bosch AD: High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin. J Neuro-Oncol 53: 267-271, 2001
17. Lippens R: Liposomal daunorubicin in children with brain tumors. Eur J Cancer 33(suppl 8): S203, 1997
18. Fabel K, Dietrich J, Hau P, Wismeth C, Winner B, Przywara S, Steinbrecher A, Ullrich W, Bogdahn U: Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 92: 1936-1942, 2001
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, Van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92: 205-216, 2000
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958
21. Steinherz LJ, Graham T, Hurwitz R, Sondheimer HM, Schwartz RG, Shaffer EM, Sandor G, Benson L, Williams R: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 89: 942-949, 1992
22. Marina NM, Cochrane D, Harney E, Zomorodi K, Blaney S, Winick N, Bernstein M, Link MP: Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: A Pediatric Oncology Group study. Clin Cancer Res 8: 413-418, 2002